share_log

基石藥業-B：臨時股東大會之代表委任表格

CSTONE PHARMA-B: FORM OF PROXY FOR EXTRAORDINARY GENERAL MEETING

香港交易所 ·  Dec 28, 2023 04:09
Summary by Moomoo AI
基石藥業-B（股份代號：2616）將於2024年1月17日舉行臨時股東大會，地點為中國上海市浦東新區海陽西路555號前灘中心三樓會議中心B廳。會議的主要議程包括審議及批准向楊博士授出購股權，以認購合共14,000,000股股份。股東大會通知於2023年12月29日發出，並提供代表委任表格，讓股東委任代表出席大會並投票。股東若無法親自出席，可委任其他代表或大會主席代為投票。所有委任表格需於大會舉行前48小時送達香港證券登記處。此外，公司亦強調收集個人資料僅用於處理股東大會相關事宜。
基石藥業-B（股份代號：2616）將於2024年1月17日舉行臨時股東大會，地點為中國上海市浦東新區海陽西路555號前灘中心三樓會議中心B廳。會議的主要議程包括審議及批准向楊博士授出購股權，以認購合共14,000,000股股份。股東大會通知於2023年12月29日發出，並提供代表委任表格，讓股東委任代表出席大會並投票。股東若無法親自出席，可委任其他代表或大會主席代為投票。所有委任表格需於大會舉行前48小時送達香港證券登記處。此外，公司亦強調收集個人資料僅用於處理股東大會相關事宜。
KEYSTONE PHARMACEUTICAL-B (STOCK CODE: 2616) WILL BE HELD ON 17 JANUARY 2024 AT THE PROVISIONAL GENERAL MEETING ON 17 JANUARY 2024 IN HALL B, 3F, CONFERENCE CENTRE, BAAN BEACH CENTRE, 555 HAIYANG WEST ROAD, PUDONG NEW DISTRICT, SHANGHAI, CHINA. The main agenda of the meeting includes the consideration and approval of the grant of a share option to Dr. Yang to subscribe for a total of 14,000,000 shares. Notice of the General Meeting issued on 29 December 2023 and a proxy form is provided for the Shareholders' Appointment to attend and vote at the General Meeting. If shareholders are unable to attend in person, they may appoint other representatives or the Chairman of the General Meeting to vote. All nomination forms must be sent to the Hong Kong Securities Registry 48 hours prior to the General Meeting. IN ADDITION, THE COMPANY EMPHASIZES THAT THE COLLECTION OF PERSONAL DATA IS USED ONLY FOR THE PURPOSE OF PROCESSING MATTERS RELATED TO THE GENERAL MEETING.
KEYSTONE PHARMACEUTICAL-B (STOCK CODE: 2616) WILL BE HELD ON 17 JANUARY 2024 AT THE PROVISIONAL GENERAL MEETING ON 17 JANUARY 2024 IN HALL B, 3F, CONFERENCE CENTRE, BAAN BEACH CENTRE, 555 HAIYANG WEST ROAD, PUDONG NEW DISTRICT, SHANGHAI, CHINA. The main agenda of the meeting includes the consideration and approval of the grant of a share option to Dr. Yang to subscribe for a total of 14,000,000 shares. Notice of the General Meeting issued on 29 December 2023 and a proxy form is provided for the Shareholders' Appointment to attend and vote at the General Meeting. If shareholders are unable to attend in person, they may appoint other representatives or the Chairman of the General Meeting to vote. All nomination forms must be sent to the Hong Kong Securities Registry 48 hours prior to the General Meeting. IN ADDITION, THE COMPANY EMPHASIZES THAT THE COLLECTION OF PERSONAL DATA IS USED ONLY FOR THE PURPOSE OF PROCESSING MATTERS RELATED TO THE GENERAL MEETING.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more